India enjoys a prominent place in the global pharmaceutical sector. In tune with it being the largest provider of generic medicines globally, the country’s pharmaceutical sector is pegged to touch a whopping US $100 billion by 2025 and US $120 billion by 2030 (1). The major drivers for this aggressive evolution include key innovation and...Continue Reading